Dr. Jeffrey R. Jay, M.D. »

Optinose shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Optinose shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Optinose

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.0012.473395M2.4733955M2.473396M2.4733965M2.473397M370.268k370.2685k370.269k370.2695k370.27k
Value ($)Share countHistorical Optinose position of Dr. Jeffrey R. … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Optinose held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Optinose by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.5M 370k 6.68

More positions owned by Dr. Jeffrey R. Jay, M.D.

Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Kalvista Pharmaceuticals (KALV)
Miragen Therapeutics (VRDN)
Pliant Therapeutics (PLRX)
Abivax Sa Sponsored Ads (ABVX)
Dynavax Technologies Corp Com New (DVAX)
Neurogene (NGNE)
Evolus (EOLS)
Xenon Pharmaceuticals (XENE)
Unicycive Therapeutics (UNCY)
Zura Bio Class A Ord Shs (ZURA)
Autolus Therapeutics Spon Ads (AUTL)
Jasper Therapeutics Com New (JSPR)
Merus N V (MRUS)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Optinose

FMR
Nantahala Capital Management
MVM Partners
Rosalind Advisors
Stonepine Capital Management
Kingdon Capital Management
Dr. Jeffrey R. Jay, M.D.
D. E. Shaw & Co
Bleichroeder
Vanguard Group
UBS Group
Geode Capital Management
Rice Hall James & Associates
GMT Capital Corp
Susquehanna International

View all funds holding Optinose